| APC | antigen-presenting cell |
| BDDCS | biopharmaceutical drug disposition categorization system |
| CAT | catalase |
| CFA | Chronic Freund’s adjuvant |
| CIA | collagen-induced arthritis |
| COX-1 | cyclooxygenase-1 |
| COX-2 | cyclooxygenase-2 |
| CRP | c-reactive protein |
| DMARD | disease-modifying antirheumatic drug |
| DMSO | dimethyl sulfoxide |
| ECM | extracellular matrix |
| ERK | extracellular signal-regulated kinase |
| EULAR | European League against Rheumatism |
| FLS | fibroblast-like synoviocyte cells |
| FoxP3 | forkhead box P3 |
| GPX | glutathione peroxidase |
| IκB-alfa | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
| IFN-gamma | interferon-gamma |
| IP-10 | interferon-gamma-inducible protein 10 kD |
| JAK/STAT | Janus kinase/signal transducers and activators of transcription |
| JNK | c-Jun N-terminal kinase |
| MAPK | mitogen-activated protein kinases |
| MCP-1 | monocyte chemoattractant protein-1 |
| MMP | matrix metalloproteinase |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NLC | nanostructure lipid carrier |
| NSAIDs | non-steroidal anti-inflammatory drugs |
| OA | osteoarthritis |
| p38-MAPK | p38 mitogen-activated protein kinases |
| PGE2 | prostaglandin E2 |
| PIK3/AKT | phosphatidylinositol 3’-kinase-Akt signaling pathway |
| PPAR-γ | peroxisome proliferator-activated receptor gamma |
| RA | rheumatoid arthritis |
| RORγt | RAR-related orphan receptor gamma |
| ROS | reactive oxygen species |
| SCW | streptococcal cell wall |
| SOD1 | superoxide dismutase type 1 |
| TGF | transforming growth factor |
| TNF-α | tumor necrosis factor |
| TRPV1 | transient receptor potential vanilloid 1 |
| VCAM-1 | vascular cell adhesion molecule 1 |
| VEGF | vascular endothelial growth factor |